HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denis Lee Selected Research

Human papillomavirus type 16 E6 protein

6/2003The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denis Lee Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 01/2004
5Infections
11/2021 - 12/2014
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 12/2014
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016 - 08/2012
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 05/2021
2Retinoblastoma (Glioblastoma, Retinal)
01/2021 - 09/2005
2Latent Infection
01/2017 - 10/2015
2Carcinogenesis
12/2010 - 01/2004
1Retinitis
01/2018
1Acquired Immunodeficiency Syndrome (AIDS)
01/2018
1Nasopharyngeal Carcinoma
01/2017
1Hairy Leukoplakia
01/2017
1Persistent Infection
01/2016
1Epstein-Barr Virus Infections
10/2015
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2015
1Papillomavirus Infections
01/2015
1Anus Neoplasms (Anal Cancer)
12/2010
1Carcinoma (Carcinomatosis)
05/2008
1Aneuploidy (Aneuploid)
01/2004
1Virus Diseases (Viral Diseases)
12/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2003
1Hyperplasia
06/2003

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2003
5Oncogene Proteins (Oncogene Protein)IBA
05/2021 - 01/2004
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 12/2003
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2021 - 09/2005
2Pharmaceutical PreparationsIBA
01/2018 - 02/2013
2Butyric Acid (Butanoic Acid)IBA
01/2017 - 10/2015
1RNA (Ribonucleic Acid)IBA
01/2022
1pembrolizumabIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Keratin-17 (Keratin 17)IBA
01/2022
1IQ motif containing GTPase activating protein 1IBA
05/2021
1VaccinesIBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2017
1ChemokinesIBA
01/2016
1Phorbol EstersIBA
10/2015
1Transcription Factors (Transcription Factor)IBA
10/2015
1Kruppel-Like Factor 4IBA
10/2015
1CytosineIBA
12/2014
1Antiviral Agents (Antivirals)IBA
12/2014
1UracilIBA
12/2014
1Cytosine DeaminaseIBA
12/2014
1Cetuximab (Erbitux)FDA Link
02/2013
1Tumor Biomarkers (Tumor Markers)IBA
02/2013
1Cisplatin (Platino)FDA LinkGeneric
02/2013
1Therapeutic UsesIBA
12/2010
1Sirolimus (Rapamycin)FDA Link
12/2010
1TOR Serine-Threonine KinasesIBA
12/2010
1Viral DNAIBA
05/2008
1Keratin-14 (Keratin 14)IBA
01/2004
1Human papillomavirus type 16 E6 proteinIBA
06/2003
1LigandsIBA
06/2003

Therapy/Procedure

2Highly Active Antiretroviral Therapy (HAART)
01/2018 - 12/2010
1Immunotherapy
01/2022
1Therapeutics
02/2013